Omeros (OMER) Accumulated Depreciation & Amortization (2011 - 2026)
Omeros recorded quarterly Accumulated Depreciation & Amortization of $12.3 million in Q1 2026, up 1127.5% quarter-over-quarter from $1.0 million in Q4 2025, and up 8.05% year-over-year from $11.4 million in Q1 2025.
Omeros' Accumulated Depreciation & Amortization history runs 16 years deep, the most recent figure standing at $12.3 million for Q1 2026.
- In Q1 2026, Accumulated Depreciation & Amortization rose 8.05% year-over-year to $12.3 million; the TTM figure through Mar 2026 stood at $12.3 million (up 8.05% YoY), while the FY2025 annual figure was $1.0 million, changed 0.0% from the prior year.
- Accumulated Depreciation & Amortization came in at $12.3 million for Q1 2026 at Omeros, up from $1.0 million in the prior quarter.
- In the past five years, Accumulated Depreciation & Amortization ranged from a high of $12.3 million in Q1 2026 to a low of $1000.0 in Q4 2022.
- A 5-year average of $7.1 million and a median of $9.5 million in 2023 frame the typical range for Accumulated Depreciation & Amortization.
- Across the five-year window, Accumulated Depreciation & Amortization tumbled 99.93% in 2022 and surged 89900.0% in 2023, its largest moves.
- Omeros' Accumulated Depreciation & Amortization stood at $1000.0 in 2022, then soared by 89900.0% to $900000.0 in 2023, then increased by 11.11% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025, then soared by 1127.5% to $12.3 million in 2026.
- According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $12.3 million, $1.0 million, and $11.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.28 Mn |
| Mar 31, 2026 | 12.28 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Sep 30, 2025 | 11.80 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Jun 30, 2025 | 11.55 Mn |
| Mar 31, 2025 | 11.36 Mn |
| Mar 31, 2025 | 11.36 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 10.77 Mn |
| Sep 30, 2024 | 10.77 Mn |
| Jun 30, 2024 | 10.54 Mn |
| Jun 30, 2024 | 10.54 Mn |
| Mar 31, 2024 | 10.45 Mn |
| Mar 31, 2024 | 10.45 Mn |
| Dec 31, 2023 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 9.84 Mn |
| Jun 30, 2023 | 9.84 Mn |
| Mar 31, 2023 | 9.51 Mn |
| Mar 31, 2023 | 9.51 Mn |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 9.44 Mn |
| Jun 30, 2022 | 9.44 Mn |
| Mar 31, 2022 | 9.31 Mn |
| Mar 31, 2022 | 9.31 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 8.71 Mn |
| Sep 30, 2021 | 8.71 Mn |
| Jun 30, 2021 | 8.39 Mn |
| Jun 30, 2021 | 8.39 Mn |
| Mar 31, 2021 | 8.04 Mn |
| Mar 31, 2021 | 8.04 Mn |
| Dec 31, 2020 | 7.65 Mn |
| Dec 31, 2020 | 7.65 Mn |
| Sep 30, 2020 | 7.25 Mn |
| Sep 30, 2020 | 7.25 Mn |
| Jun 30, 2020 | 6.85 Mn |
| Jun 30, 2020 | 6.85 Mn |
| Mar 31, 2020 | 6.44 Mn |
| Mar 31, 2020 | 6.44 Mn |
| Dec 31, 2019 | 6.04 Mn |
| Dec 31, 2019 | 6.04 Mn |
| Sep 30, 2019 | 5.51 Mn |
| Sep 30, 2019 | 5.51 Mn |
| Jun 30, 2019 | 5.07 Mn |
| Jun 30, 2019 | 5.07 Mn |
| Mar 31, 2019 | 377,000.00 |
| Mar 31, 2019 | 377,000.00 |
| Dec 31, 2018 | 962,000.00 |
| Dec 31, 2018 | 962,000.00 |
| Mar 31, 2018 | 223,000.00 |
| Mar 31, 2018 | 223,000.00 |
| Dec 31, 2017 | 551,000.00 |
| Dec 31, 2017 | 551,000.00 |
| Dec 31, 2016 | 300,000.00 |
| Dec 31, 2016 | 300,000.00 |
| Dec 31, 2015 | 209,000.00 |
| Dec 31, 2015 | 209,000.00 |
| Dec 31, 2014 | 317,000.00 |
| Dec 31, 2014 | 317,000.00 |
| Dec 31, 2013 | 302,000.00 |
| Dec 31, 2013 | 302,000.00 |
| Dec 31, 2012 | 1.79 Mn |
| Dec 31, 2012 | 1.79 Mn |
| Dec 31, 2011 | 2.48 Mn |
| Dec 31, 2011 | 2.48 Mn |